Advertisement
Singapore markets open in 1 hour 58 minutes
  • Straits Times Index

    3,348.87
    +12.28 (+0.37%)
     
  • S&P 500

    5,283.40
    +5.89 (+0.11%)
     
  • Dow

    38,571.03
    -115.29 (-0.30%)
     
  • Nasdaq

    16,828.67
    +93.65 (+0.56%)
     
  • Bitcoin USD

    69,032.30
    +1,132.24 (+1.67%)
     
  • CMC Crypto 200

    1,447.40
    -20.53 (-1.40%)
     
  • FTSE 100

    8,262.75
    -12.63 (-0.15%)
     
  • Gold

    2,371.00
    +1.70 (+0.07%)
     
  • Crude Oil

    74.05
    -0.17 (-0.23%)
     
  • 10-Yr Bond

    4.4020
    -0.1120 (-2.48%)
     
  • Nikkei

    38,923.03
    +435.13 (+1.13%)
     
  • Hang Seng

    18,403.04
    +323.43 (+1.79%)
     
  • FTSE Bursa Malaysia

    1,596.68
    -7.58 (-0.47%)
     
  • Jakarta Composite Index

    7,036.19
    -6,970.74 (-49.77%)
     
  • PSE Index

    6,470.74
    +37.64 (+0.59%)
     

Bayer reports $4.35 billion full-year net profit

Bayer's full-year net profit jumps by a third to $4.35 billion as sales hit record high

BERLIN (AP) -- Bayer AG says its net profit jumped by almost a third last year to 3.19 billion euros ($4.35 billion) as sales hit a record high.

This compares with a net profit of 2.91 billion euros in 2012. Fourth-quarter net profits rose 24 percent to 455 million euros.

The German drug and chemical company says revenues reached 40.16 billion euros in 2013, an increase of about 1 percent year-on-year.

Board chairman Marijn Dekkers said Friday that the Leverkusen-based company expects sales of 41-42 billion euros in 2014.

The company announced Thursday that it is buying Dihon Pharmaceutical Group Co., a manufacturer of over-the-counter medicines and Chinese herbal products, for an undisclosed sum.

Bayer shares rose 0.8 percent to 100.65 euros in early trading on the Frankfurt exchange.